IL4 and celiac disease: When further studies will confirm the relevance of TCRγδ+ and IL4+ T cells as specific biomarkers of CD lesion evolution, their detection can be applied in clinical practice to assess the efficacy of new drugs for celiac disease treatment alternative to a gluten-free diet [35].